A scientifically based approach that includes a tooth-decay risk
assessment, aggressive preventive measures and conservative restorations
can dramatically reduce decay in community dental practices, according
to a study by researchers at UC San Francisco.
The findings, which support earlier research demonstrating positive
results of the assessment and treatment method in a university setting,
have the potential to transform dental care for high-risk patients at a
lower cost to both patients and dental clinics and practices. Results
appear online Jan. 22, 2018, in
Advances in Dental Research.
"We put the 2012 UCSF clinical study into the real world and showed
it works," said lead author Peter Rechmann, DMD, PhD, professor of
preventive and restorative dental sciences in the UCSF School of
Dentistry. "The patients at high caries risk who used prescription
products went down significantly over time in their risk level. Those in
the control group also reduced their risk to a lesser degree, simply by
using over-the-counter products that also protect teeth and affect the
bacteria."
Dental caries (tooth decay) is caused by bacteria on the tooth
surface feeding on carbohydrates, then making acids as waste. These
acids destroy the protective tooth enamel and the dentin layer beneath
it. If not halted or reversed, this leads to a cavity.
CAries Management By Risk Assessment (CAMBRA?) is an evidence-based
approach to preventing or treating dental caries at its earliest stages.
It was launched in 2003 through the UCSF School of Dentistry by the
paper's senior author, John Featherstone, PhD, MSc, former dean of the
school and distinguished professor of preventive and restorative dental
sciences.
A dentist who uses CAMBRA obtains the patient's dental and medical
history and conducts a clinical exam to assess caries early enough to
reverse or halt progression and to determine caries risk factors. These
factors include, among other things, acid-producing bacteria, frequent
eating and drinking of fermentable carbohydrates ("snacking"), and
abnormally low saliva flow and function.
From this assessment, the dentist utilizes behavioral approaches and
chemical treatments to optimize protective factors. The treatment plan
typically incorporates remineralization through the use of fluoride
and/or antibacterial therapies such as chlorhexidine and xylitol,
minimally invasive restorative procedures to conserve tooth structure,
and regular patient follow up.
The authors published their initial validation of CAMBRA for ages 6
through adult in 2006, followed by several additional years of data
published in 2011, 2012, 2015 and 2016. Since then, more than half of
the U.S. schools and colleges of dentistry have adopted CAMBRA in one
form or another as part of their standard curriculum. The authors said
now that this has been shown to be effective in a non-academic clinical
setting, there also is potential for insurance companies to reimburse
CAMBRA and other preventive therapies for adults, thereby lowering
patient costs while increasing profits for dental practices.
Treatment Effective Even Without Prescription Products
In the Advances in Dental Research study, Rechmann and his
colleagues recruited 20 dentists - 17 in private practice, three in
community clinics - to participate in a two-year CAMBRA trial of 460
patients ages 12-65 years old, with 239 in a CAMBRA group and 221 in a
control group.
In the CAMBRA group, high-risk patients received prescription
fluoride toothpaste, chlorhexidine antibacterial rinse, xylitol mints
and fluoride varnish. The control group received regular fluoride
toothpaste, an assumed inactive mouth rinse, sorbitol candies and a
non-fluoride varnish.
Follow-up visits occurred at six, 12, 18 and 24 months, in which new
caries lesions or changes in caries risk level were recorded. Overall,
the researchers found that a significantly greater percentage of
high-risk participants were classified at lower risk after receiving
CAMBRA preventive therapies. Dental decay was low in both groups.
Among 242 patients (137 intervention, 105 control) initially
identified as high risk for caries, only a quarter of the patients
remained at high risk in the CAMBRA group at 24 months, while just over
half (54 percent) of the control group did. Of the 192 low-risk
participants (93 intervention, 99 control), most participants remained
low risk, indicating that the assessment correctly identifies who is at
risk for caries.
The researchers said the risk reduction among the control group may
have been caused by the fluoride toothpaste enhancing tooth repair, as
well as the mouth rinse enhancing saliva flow and having bactericidal
effects. While not as significant as the CAMBRA group in this study, the
risk level of these patients dropped more dramatically over time than
for those in the 2012 UCSF CAMBRA study.
"It was surprising to see the benefits gained by the control group,"
Rechmann said. "More research is needed to see if the products and
treatment administered to this group function in the way we speculate,
and if so, they might be made easily available to dental patients. Doing
so can change the whole picture of caries control."
Among the study limitations, the researchers noted a high study
attrition (65 percent), which partly may have contributed to observed
declines in risk level at each subsequent recall visit.